Majestic Dragon AeroTech Holdings Limited (HKG:0918)
Hong Kong · Delayed Price · Currency is HKD 0.5700
-0.0100 (-1.72%)
Aug 14, 2025, 10:39 AM HKT
Lumos Pharma Income Statement
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 118.79 | 245.98 | 206.54 | 207.23 | 276.89 | Upgrade | |
Revenue Growth (YoY) | -51.71% | 19.10% | -0.33% | -25.16% | 31.74% | Upgrade |
Cost of Revenue | 93.28 | 190.63 | 168.75 | 172.08 | 230.44 | Upgrade |
Gross Profit | 25.51 | 55.35 | 37.79 | 35.15 | 46.45 | Upgrade |
Selling, General & Admin | 46.16 | 47.12 | 25.75 | 16.66 | 25.73 | Upgrade |
Other Operating Expenses | -0.29 | -0.07 | -0.29 | - | - | Upgrade |
Operating Expenses | 42.28 | 116.65 | 35.21 | 33.82 | 28.61 | Upgrade |
Operating Income | -16.77 | -61.3 | 2.58 | 1.33 | 17.84 | Upgrade |
Interest Expense | -1.97 | -3.02 | -1.42 | -0.3 | -2.84 | Upgrade |
Interest & Investment Income | 1.16 | 1.12 | 0.4 | 2.1 | 0 | Upgrade |
Currency Exchange Gain (Loss) | 0.67 | -2.25 | -5.71 | 0.19 | 0.39 | Upgrade |
Other Non Operating Income (Expenses) | - | - | - | 0.04 | 1.95 | Upgrade |
EBT Excluding Unusual Items | -16.92 | -65.45 | -4.15 | 3.36 | 17.34 | Upgrade |
Impairment of Goodwill | -0.7 | - | - | - | - | Upgrade |
Gain (Loss) on Sale of Investments | -0.05 | -0.17 | -0.31 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | - | 0.13 | - | - | 0.25 | Upgrade |
Asset Writedown | -5.33 | -3.12 | -1.63 | -13.42 | -5.34 | Upgrade |
Other Unusual Items | 0.28 | 1.36 | 0.22 | 0.55 | 1.14 | Upgrade |
Pretax Income | -22.72 | -67.25 | -5.87 | -9.52 | 13.39 | Upgrade |
Income Tax Expense | -1.42 | -0.67 | 0.88 | 2.2 | 3.14 | Upgrade |
Earnings From Continuing Operations | -21.3 | -66.58 | -6.75 | -11.72 | 10.25 | Upgrade |
Earnings From Discontinued Operations | - | 8.21 | -17.91 | - | - | Upgrade |
Net Income to Company | -21.3 | -58.36 | -24.65 | -11.72 | 10.25 | Upgrade |
Minority Interest in Earnings | - | - | - | - | -2.64 | Upgrade |
Net Income | -21.3 | -58.36 | -24.65 | -11.72 | 7.61 | Upgrade |
Net Income to Common | -21.3 | -58.36 | -24.65 | -11.72 | 7.61 | Upgrade |
Net Income Growth | - | - | - | - | -18.79% | Upgrade |
Shares Outstanding (Basic) | 1,114 | 983 | 774 | 550 | 160 | Upgrade |
Shares Outstanding (Diluted) | 1,114 | 983 | 774 | 550 | 160 | Upgrade |
Shares Change (YoY) | 13.29% | 27.10% | 40.61% | 243.22% | 3.37% | Upgrade |
EPS (Basic) | -0.02 | -0.06 | -0.03 | -0.02 | 0.05 | Upgrade |
EPS (Diluted) | -0.02 | -0.06 | -0.03 | -0.02 | 0.05 | Upgrade |
EPS Growth | - | - | - | - | -21.44% | Upgrade |
Free Cash Flow | 29.8 | -35.85 | -76.47 | 11.58 | -17.63 | Upgrade |
Free Cash Flow Per Share | 0.03 | -0.04 | -0.10 | 0.02 | -0.11 | Upgrade |
Gross Margin | 21.47% | 22.50% | 18.30% | 16.96% | 16.78% | Upgrade |
Operating Margin | -14.12% | -24.92% | 1.25% | 0.64% | 6.44% | Upgrade |
Profit Margin | -17.93% | -23.73% | -11.94% | -5.65% | 2.75% | Upgrade |
Free Cash Flow Margin | 25.09% | -14.57% | -37.02% | 5.59% | -6.37% | Upgrade |
EBITDA | -8.65 | -54.83 | 5.87 | 2.91 | 19.6 | Upgrade |
EBITDA Margin | -7.28% | -22.29% | 2.84% | 1.40% | 7.08% | Upgrade |
D&A For EBITDA | 8.12 | 6.46 | 3.29 | 1.58 | 1.76 | Upgrade |
EBIT | -16.77 | -61.3 | 2.58 | 1.33 | 17.84 | Upgrade |
EBIT Margin | -14.12% | -24.92% | 1.25% | 0.64% | 6.44% | Upgrade |
Effective Tax Rate | - | - | - | - | 23.47% | Upgrade |
Updated Dec 17, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.